ShadowBuys
Sign inJoin for free

Sen. David Perdue sold Johnson & Johnson (JNJ)

Sen. David Perdue (R-GA) · $1K–$15K · traded Apr 16, 2020

Transaction
Sold (full)
Amount
$1K–$15K
Owner
Joint
Traded
Apr 16, 2020
Disclosed
May 8, 2020
Days to disclose
22
Asset type
Stock
As filed
Johnson & Johnson
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Perdue's tradesAll Congress trades in JNJ

Other trades in this filing

All of Perdue's trades →

Recent Congress trades in JNJ

Company context for JNJ

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. JNJFinancial report·SEC EDGAR

    JNJ: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.

    Public: Oct 21, 2026, 4:18 PM EDTEvent / period: Sep 27, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    Issues related to the 340B Drug Pricing Program. Issues related to the 340B Drug Pricing Program.

    Public: Oct 20, 2026, 12:00 AM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    HR 6549, VA Contracting and Procurement Act PBM Medical Supply Chain program reforms, MSPV, PSAS, IT HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act

    Public: Oct 16, 2026, 12:14 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.